Dr. West is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Fourth St
Stop 9400
Lubbock, TX 79430Phone+1 806-743-1842
Education & Training
Texas Tech University Health Sciences Center at LubbockResidency, Dermatology, 2013 - 2016
University of Kansas (Wichita)Residency, Radiology-Diagnostic, 2010 - 2011- University of Kansas (Wichita)Internship, Internal Medicine, 2009 - 2010
University of Kansas School of MedicineClass of 2009
Certifications & Licensure
TX State Medical License 2022 - 2026
KS State Medical License 2016 - 2025
MN State Medical License 2016 - 2025
NM State Medical License 2012 - 2013
NC State Medical License 2011 - 2012- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
- National Board of Physicians and Surgeons Dermatology
Publications & Presentations
PubMed
- GZ17-6.02 kills PDX isolates of uveal melanoma.Laurence Booth, Jane L Roberts, Ivan Spasojevic, Kaitlyn C Baker, Andrew Poklepovic
Oncotarget. 2024-05-17 - 3 citationsTreatment of pyoderma gangrenosum with apremilast monotherapy.Zachary A Bordeaux, Shawn G Kwatra, Cameron E West
JAAD Case Reports. 2022-12-01 - 2 citationsMelanocytic Panfolliculoma: A Case Report of a Rare Benign Follicular Tumor.Allie Preston, Cameron West, Martha McCollough, Gregory A Hosler
The American Journal of Dermatopathology. 2022-04-01
Press Mentions
First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research InstituteMarch 20th, 2019
First-in-Human Trial Launched for Super-Enhancer Inhibitor GZ17-6.02November 25th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
